Product Information

OMEGA-3 ETHYL ESTERS 1 GM CAP is a generic product labeled by Bionpharma Inc., priced at $0.1726 per EA under NDC 69452017522. Its NADAC has been published 328 times since Feb 12, 2020.

FDA first approved this application on Aug 7, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the omega-3-acid ethyl esters market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OMEGA-3 ETHYL ESTERS 1 GM CAP

omega-3-acid ethyl esters
$0.1726per EA
High Outlier

Strength

900 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452017522

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

5/20/2026

Active Ingredients

OMEGA-3-ACID ETHYL ESTERS

Approval Type

Generic (ANDA)

FDA Application

ANDA206455

FDA Approved

8/7/2019

TE Code

AB

On Market Since

1/15/2017

Pharmacological Classes

Fatty Acids
Omega-3
Omega-3 Fatty Acid

Price Statistics

The NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has been published 328 times since Feb 12, 2020, and over the history we have for it it has declined 32.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1726 per EA
All-time high$0.2580 (Jun 10, 2020)
All-time low$0.1537 (Jan 18, 2023)
52-week high$0.1726
52-week low$0.1652
Median price$0.1790
Average price$0.1871
Largest weekly change-19.9% (Mar 17, 2021)
Weeks tracked328
Tracking sinceFeb 12, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

+0.4%

1Y

+3.1%

3Y

+3.1%

5Y

-10.4%

All

-32.8%

Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OMEGA-3 ETHYL ESTERS 1 GM CAP?

The current National Average Drug Acquisition Cost (NADAC) for OMEGA-3 ETHYL ESTERS 1 GM CAP, manufactured by Bionpharma Inc., is $0.1726 per EA (NDC 69452017522), effective May 20, 2026.

How has the price of OMEGA-3 ETHYL ESTERS 1 GM CAP changed over time?

Over the history we have for it, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has declined 32.8%. It has been tracked across 328 weekly CMS publications since Feb 12, 2020.

What are the highest and lowest recorded NADAC prices for OMEGA-3 ETHYL ESTERS 1 GM CAP?

Since Feb 12, 2020, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has ranged from a low of $0.1537 (Jan 18, 2023) to a high of $0.2580 (Jun 10, 2020), with a median of $0.1790 per EA.

Are there cheaper alternatives to OMEGA-3 ETHYL ESTERS 1 GM CAP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEGA-3 ETHYL ESTERS 1 GM CAP, is $0.1711 per EA — about 1% below OMEGA-3 ETHYL ESTERS 1 GM CAP.

Who manufactures OMEGA-3 ETHYL ESTERS 1 GM CAP?

OMEGA-3 ETHYL ESTERS 1 GM CAP (NDC 69452017522) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.